SeaStar Medical is a commercial-stage medical device company that develops immunomodulating technologies.
SeaStar Medical has raised $4.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.
SeaStar Medical's investors include National Heart, Lung and Blood Institute.
SeaStar Medical is headquartered in Denver, United States.
SeaStar Medical is a commercial-stage medical device company that develops immunomodulating technologies.
SeaStar Medical is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SeaStar Medical — Funding & Investors." VCBacked, July 31, 2025, https://www.vcbacked.co/company/seastar-medical. Accessed October 1, 2026.
VCBacked. (2025). SeaStar Medical — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/seastar-medical
{{cite web |title=SeaStar Medical — Funding & Investors |url=https://www.vcbacked.co/company/seastar-medical |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated